IDIOPATHIC INFLAMMATORY MYOPATHIES
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHIES explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHIES trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy trial offers hope for severe muscle disease patients
Disease control Recruiting nowThis study is testing a new type of treatment called rapcabtagene autoleucel, a CAR-T cell therapy, for adults with severe inflammatory muscle diseases that haven't responded to other treatments. It will compare this new therapy against a standard treatment option to see which is…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists test 'Living Drug' to reboot immune system in autoimmune patients
Disease control Recruiting nowThis is an early-stage safety study testing a new type of personalized cell therapy called AZD0120. It aims to see if this treatment is safe and tolerable for adults with severe autoimmune diseases like systemic sclerosis, inflammatory myopathies, or difficult-to-treat rheumatoid…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Early trial tests new drug duo for rare Muscle-Wasting disease
Disease control Recruiting nowThis is a small, early-stage pilot study testing whether a combination of two drugs, pozelimab and cemdisiran, can help control the progression of sporadic inclusion body myositis (sIBM), a rare muscle-wasting disease. Ten participants will receive injections every four weeks for…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: EARLY_PHASE1 • Sponsor: Austin Neuromuscular Center • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Early trial tests 'Living Drug' for tough autoimmune illnesses
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy called NKX019 in people with severe autoimmune diseases like systemic sclerosis, inflammatory muscle disease, and certain types of vasculitis. The main goals are to find a safe dose and see if the treatment is tolerable…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1, PHASE2 • Sponsor: Nkarta, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New drug enters human testing for three debilitating autoimmune conditions
Disease control Recruiting nowThis early-stage study aims to test the safety and basic effects of a new experimental drug called AZD5492 in adults with lupus, inflammatory muscle diseases, or rheumatoid arthritis. Researchers will give participants one or two doses and closely monitor them for side effects an…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Cancer-Fighting cell therapy tested against lupus and other autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing whether a type of cell therapy called CAR-T, which is used to treat some cancers, can help people with serious autoimmune diseases like lupus, scleroderma, and vasculitis. The therapy involves collecting a patient's own immune cells, modifying th…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC